Show simple item record

Remdesivir treatment for patients with moderate to severe COVID-19

dc.contributor.authorÜNAL, SERHAT
dc.contributor.authorErdinc, Sebnem
dc.contributor.authorTabak, Fehmi
dc.contributor.authorGül, Ahmet
dc.contributor.authorAlp, Emine
dc.contributor.authorSevgi, Dilek Yildiz
dc.contributor.authorCagatay, Arif Atahan
dc.contributor.authorBozkurt, Ilkay
dc.contributor.authorYasar, Kadriye Kart
dc.contributor.authorSenoglu, Sevtap
dc.contributor.authorHASANOĞLU, İMRAN
dc.contributor.authorGuner, Rahmet
dc.contributor.authorCelik, Ilhami
dc.contributor.authorKANAT, FİKRET
dc.contributor.authorBatirel, Ayse
dc.contributor.authorTELLİ DİZMAN, GÜLÇİN
dc.contributor.authorEren, Esma
dc.contributor.authorKAZAK, ESRA
dc.contributor.authorKARAALİ, RIDVAN
dc.contributor.authorCelikbas, Aysel
dc.contributor.authorPULLUKÇU, HÜSNÜ
dc.date.accessioned2023-02-21T10:08:32Z
dc.date.available2023-02-21T10:08:32Z
dc.date.issued2022
dc.identifier.citationHASANOĞLU İ., Guner R., Celik I., KANAT F., Batirel A., TELLİ DİZMAN G., Eren E., Sevgi D. Y., Bozkurt I., Yasar K. K., et al., "Remdesivir treatment for patients with moderate to severe COVID-19", TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.4, ss.880-887, 2022
dc.identifier.issn1300-0144
dc.identifier.othervv_1032021
dc.identifier.otherav_3d334c46-090c-4756-831a-41c821b37654
dc.identifier.urihttp://hdl.handle.net/20.500.12627/188135
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/3d334c46-090c-4756-831a-41c821b37654/file
dc.identifier.urihttps://doi.org/10.55730/1300-0144.5387
dc.description.abstractBackground/aim: Remdesivir, which was first developed for the treatment of Ebola disease but failed to meet expectations, has become hope in the fight against the COVID-19 pandemic. This study aimed to evaluate risk factors for mortality and prognosis of adult moderate/severe COVID-19 patients treated with remdesivir, and safety and tolerability of 5 days of remdesivir treatment.
dc.language.isoeng
dc.subjectPatofizyoloji
dc.subjectTemel Bilgi ve Beceriler
dc.subjectDeğerlendirme ve Teşhis
dc.subjectDahiliye
dc.subjectAile Sağlığı
dc.subjectTıp (çeşitli)
dc.subjectGenel Tıp
dc.subjectTIP, GENEL & DAHİLİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectGenel Sağlık Meslekleri
dc.titleRemdesivir treatment for patients with moderate to severe COVID-19
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF MEDICAL SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume52
dc.identifier.issue4
dc.identifier.startpage880
dc.identifier.endpage887
dc.contributor.firstauthorID4077201


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record